Virus interference and estimates of influenza vaccine effectiveness from test-negative studies

Epidemiology

Volumn 23, Issue 6, 2012, Pages 930-931

  Cowling, Benjamin J ^a   Nishiura, Hiroshi ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

CASE CONTROL STUDY; DRUG EFFICACY; HUMAN; INFECTION RISK; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; LETTER; OBSERVATIONAL STUDY; PRIORITY JOURNAL; UPPER RESPIRATORY TRACT INFECTION; VACCINATION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS TRANSMISSION;

CASE-CONTROL STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 84867513648     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31826b300e     Document Type: Letter

References (15)

1. Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analy-sis. Lancet Infect Dis. 2012;12:36-44.
2. Kelly H, Jacoby P, Dixon GA, et al; WAIVE Study Team. Vaccine Effectiveness Against Laboratory-confirmed Influenza in Healthy Young Children: a case-control study. Pediatr Infect Dis J. 2011;30:107-111.
3. Orenstein E W, De Serres G, Haber MJ, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36:623-631.
4. Valenciano M, Kissling E, Ciancio BC, Moren A. Study designs for timely estimation of influenza vaccine effectiveness using European sentinel practitioner networks. Vaccine. 2010;28:7381-7388.
5. Skowronski DM, Gilbert M, Tweed SA, et al. Effectiveness of vaccine against medical consultation due to laboratory-confirmed influenza: results from a sentinel physician pilot project in British Columbia, 2004-2005. Canada Communicable Dis Rep. 2005;31: 181-191.
6. Skowronski DM, De Serres G, Crowcroft NS, et al; Canadian SAVOIR Team. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med. 2010;7:e1000258.
7. Belongia EA, Kieke BA, Donahue JG, et al. Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results. Vaccine. 2011;29:6558-6563.
8. Kissling E, Valenciano M, Cohen JM, et al. I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe. PLoS ONE. 2011;6:e27622.
9. McGill J, Heusel J W, Legge KL. Innate immune control and regulation of influenza virus infections. J Leukoc Biol. 2009;86:803-812.
10. Khaitov MR, Laza-Stanca V, Edwards MR, et al. Respiratory virus induction of alpha-, beta-and lambda-interferons in bronchial epithelial cells and peripheral blood mononuclear cells. Allerg y. 2009;64:375-386.
11. Anestad G. Interference between outbreaks of respiratory syncytial virus and influenza virus infection. Lancet. 1982;1:502.
12. Berencsi G, Kapusinszky B, Rigó Z, Szomor K. Interference among viruses circulating and administered in Hungary from 1931 to 2008. Acta Microbiol Immunol Hung. 2010;57:73-86.
13. Linde A, Rotzén-Ostlund M, Zweygberg-Wirgart B, Rubinova S, Brytting M. Does viral interference affect spread of influenza? Euro Surveill. 2009;14:19354.
14. Cowling BJ, Fang VJ, Nishiura H, et al. Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine. Clin Infect Dis. 2012;54:1778-1783.
15. Halloran ME, Longini IM, Struchiner CJ. Design and Analysis of Vaccine Studies (Statistics for Biology and Health) New York: Springer-Verlag; 2009.